Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
OMX Copenhagen Personal & Household Goods PI | CX4020PI | Mar 27, 2024 | 5 387.19 | -2.18 |
OMX Copenhagen PI | OMXCPI | Mar 27, 2024 | 1 863.41 | -0.44 |
OMX Copenhagen Real Estate PI | CX35PI | Mar 27, 2024 | 2 050.55 | +0.16 |
OMX Copenhagen Retail PI | CX4040PI | Mar 27, 2024 | 928.41 | -0.30 |
OMX Copenhagen Small Cap GI | OMXCSCGI | Mar 27, 2024 | 187.02 | +0.33 |
OMX Copenhagen Small Cap PI | OMXCSCPI | Mar 27, 2024 | 528.09 | +0.33 |
OMX Copenhagen Technology PI | CX10PI | Mar 27, 2024 | 7 733.35 | +0.77 |
OMX Copenhagen Travel & Leisure PI | CX4050PI | Mar 27, 2024 | 857.30 | +1.14 |
OMX Copenhagen Utilities PI | CX65PI | Mar 27, 2024 | 517.66 | +2.56 |
OMXC20 | OMXC20 | Mar 27, 2024 | 2 669.49 | -0.67 |
OrderYOYO | YOYO | Mar 27, 2024 | 7.00 | -2.78 |
Orphazyme | ORPHA | Mar 27, 2024 | 1 199.80 | +0.84 |
Pandora | PNDORA | Mar 27, 2024 | 1 114.50 | -2.28 |
Park Street A | PARKSTA | Mar 27, 2024 | 11.80 | +2.61 |
PARKEN Sport & Entertainment | PARKEN | Mar 27, 2024 | 127.50 | +0.79 |
Penneo | PENNEO | Mar 27, 2024 | 7.78 | -0.26 |
Per Aarsleff Holding B | PAALB | Mar 27, 2024 | 345.00 | -0.29 |
Pharma Equity Group | PEG | Mar 27, 2024 | 0.36 | +3.45 |
Prime Office | PRIMOF | Mar 27, 2024 | 176.00 | -2.22 |
Q-Interline | QINTER | Mar 27, 2024 | 8.08 | +1.00 |
Relesys | RELE | Mar 27, 2024 | 5.90 | +3.51 |
Rias B | RIASB | Mar 27, 2024 | 660.00 | 0.00 |
Ringkjøbing Landbobank | RILBA | Mar 27, 2024 | 1 209.00 | -0.82 |
RISMA Systems | RISMA | Mar 27, 2024 | 8.55 | +0.59 |
Roblon B | RBLNB | Mar 27, 2024 | 85.20 | +0.47 |
Rockwool AS, ser A | ROCKA | Mar 27, 2024 | 2 250.00 | +2.27 |
Rockwool AS, ser B | ROCKB | Mar 27, 2024 | 2 269.00 | +2.21 |
Rovsing | ROV | Mar 27, 2024 | 37.00 | 0.00 |
Royal UNIBREW | RBREW | Mar 27, 2024 | 456.70 | +1.76 |
RTX | RTX | Mar 27, 2024 | 97.20 | +0.21 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.